David Pendley, MD
Internal Medicine · Gulfport, MSNPI 1548217896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Abbott at 45.3% of the total. Reporting peaked in 2020 at $336 and has fallen 91.4% since, to $29 in 2024.
Across 53 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$405
- Dexcom, Inc.$118
- Insulet Corporation$66
- Lilly USA, LLC$62
- Boehringer Ingelheim$39
- Corcept Therapeutics$36
- plus $169 from 8 others
Across 16 payments — averaging $20,954 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$319K
- AstraZeneca$16K
- Teva Pharmaceuticals USA, Inc.$216
What the payments were for
- Food & beverage$896100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 30 | $405 |
| Dexcom, Inc. | 2 | $118 |
| Insulet Corporation | 3 | $66 |
| Lilly USA, LLC | 4 | $62 |
| Boehringer Ingelheim | 2 | $39 |
| Corcept Therapeutics | 2 | $36 |
| AstraZeneca | 2 | $30 |
| Medtronic(2 entities) | 2 | $30 |
| Merck | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Novo Nordisk | 1 | $13 |
| Companion Medical, Inc. | 1 | $12 |
| Tandem Diabetes Care, Inc. | 1 | $11 |
How this compares
$896 in reported general payments places this provider in the 60th percentile of 846 internal medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Gulfport
- Mousa MaaloufGulfport$14K
- David LarosaGulfport$14K
- Phillip ComptonGulfport$10K
- Lynn LeatherwoodGulfport$10K
- Jay SegarraGulfport$9K
- Boyd BenefieldGulfport$7K
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Indira VeerisettyRidgeland$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.